Skip to main content
. Author manuscript; available in PMC: 2022 Jan 12.
Published in final edited form as: Oral Oncol. 2021 Jul 1;120:105420. doi: 10.1016/j.oraloncology.2021.105420

Figure 3. Immunosuppressive targets throughout the tumor immunity cycle.

Figure 3.

Immunosurveillance involves (1) a process of released antigens from tumor cells, (2) presentation of tumor-associated antigens to antigen presenting cells, (3) chemotrafficking of immune effector cells into the tumor microenvironment, and (4) immune effector cell recognition and killing of the cancer cell. Tumors can evade the immune system throughout the tumor immunity cycle (dashed outlines).